KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Sales (2016 - 2025)

TherapeuticsMD (TXMD) has disclosed Return on Sales for 16 consecutive years, with 0.13% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 21.0% year-over-year to 0.13%, compared with a TTM value of 0.08% through Sep 2025, down 33.0%, and an annual FY2024 reading of 0.07%, up 206.0% over the prior year.
  • Return on Sales was 0.13% for Q3 2025 at TherapeuticsMD, up from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 365.39% in Q2 2022 and bottomed at 44.81% in Q1 2022.
  • Average Return on Sales over 5 years is 12.5%, with a median of 0.04% recorded in 2025.
  • The sharpest move saw Return on Sales soared 36724bps in 2022, then plummeted -36519bps in 2023.
  • Year by year, Return on Sales stood at 0.65% in 2021, then crashed by -35bps to 0.43% in 2022, then skyrocketed by 207bps to 1.31% in 2023, then plummeted by -84bps to 0.21% in 2024, then crashed by -37bps to 0.13% in 2025.
  • Business Quant data shows Return on Sales for TXMD at 0.13% in Q3 2025, 0.01% in Q2 2025, and 0.04% in Q1 2025.